Following some clean sweeps in PhIII, AbbVie gets an FDA OK on its top-10 blockbuster prospect Orilissa
One of the year’s top prospective blockbuster approvals just came through.
AbbVie $ABBV says that they just nabbed an FDA OK for elagolix — the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
